AZD 2066 is a selective, orally active and brain-penetrant mGluR5 antagonist, with analgesia activity[1].
[1]. Swedberg MD, et al. AZD9272 and AZD2066: selective and highly central nervous system penetrant mGluR5 antagonists characterized by their discriminative effects. J Pharmacol Exp Ther. 2014 Aug;350(2):212-22.
















